CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Glenmark Pharmaceuticals Inc., USA recalls Ezetimibe and Simvastatin…

Glenmark Pharmaceuticals Inc., USA recalls Ezetimibe and Simvastatin Tablets

Read the official FDA notice

Published
18 Jun 2025
Units affected
6,759 Con - 90 bottle pack
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time point during long-term stability study.

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Ezetimibe and Simvastatin Tablets, 10mg/40mg, 90-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Madya Pradesh, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-323-90

Brand / company
Glenmark Pharmaceuticals Inc., USA
Codes / lots
Lot #: 17240195, Exp 01/31/2026.
Distribution
Nationwide USA and PR
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 18 Jun 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.